Posted on 12/11/20
FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine
An advisory committee to the U.S. Food and Drug Administration (FDA) voted late on Thursday to recommend that emergency use authorization (EUA) be given to Pfizer's . . .
Posted on 12/11/20
Nabriva Therapeutics Prices of $15 Million Public Offering
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and . . .
Posted on 12/10/20
Nabriva Therapeutics Announces Proposed Public Offering
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and . . .
Posted on 12/10/20
A Low-cost COVID-19 Test That Could Give Results in Under 5 Minutes is in Development at Penn
Early this year, before much of the U.S. was concerned with the novel coronavirus, University of Pennsylvania’s César
Posted on 12/10/20
Renovus Capital Partners to Sell Clinical Education Alliance
Renovus Capital Partners, a Philadelphia-area private equity firm, announced today that it has signed a definitive agreement to sell its portfolio company Clinical Education Alliance (CEA)
Posted on 12/10/20
Gilead Sciences to Buy MYR GmbH for $1.15 Billion
Gilead Sciences, Inc. (Nasdaq: GILD) acquired MYR GmbH, a Bad Homburg, Germany-based biotechnology company focused on the development and commercialization of therapeutics
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/10/20
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
We could be only days away from the first two emergency use authorizations (EUA) for COVID-19 vaccines in the U.S. An FDA advisory committee meets on . . .
Posted on 12/10/20
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are heading for the finish line in the coronavirus vaccine race. The U.S. Food and Drug Administration will meet with advisory . . .
Posted on 12/10/20
Is Johnson & Johnson a Great Dividend Stock?
A seemingly "boring" product line up can often make a company a great investment. Think about how many mundane things like shampoo or skin moisturizer you . . .
Posted on 12/10/20
Could Pfizer Be a Millionaire-Maker Stock?
In the past month, Pfizer (NYSE:PFE) stock is up over 20% on the enthusiasm that it will be the first company in the world to bring . . .
Posted on 12/9/20
Neuronetics Amendment of Credit Facility with Solar Capital Partners
MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that . . .
Posted on 12/9/20
ADMA Biologics Enters Into $100 Million Credit Facility
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing . . .
Posted on 12/9/20
Pfizer's Coronavirus Vaccine Is 52.4% Effective After First Dose
On Monday morning, the FDA published briefing documents for an upcoming meeting of a panel of independent medical experts who will weigh in on data from . . .
Posted on 12/9/20
Why Shares of iBio, Marinus Pharmaceuticals, and Arcturus Therapeutics All Crashed on Tuesday
What happenedOn Tuesday, shares of up-and-coming biotechs Marinus Pharmaceuticals (NASDAQ:MRNS), iBio (NYSEMKT:IBIO), and Arcturus Therapeutics Holdings (NASDAQ:ARCT) fell by 12%, 13%, and 19%, respectively.One common catalyst . . .
Posted on 12/8/20
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2021
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020.First quarter 2021 net sales were $297.0M, up 15.5% compared . . .
Posted on 12/8/20
Marinus Pharmaceuticals Prices of $70 Million Public Offering of Common Stock
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing . . .
Posted on 12/8/20
Trinity Life Sciences Acquires BluePrint Research Group
Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity
Posted on 12/8/20
Agile Therapeutics: Managing A Position Ahead Of Twirla's Launch
SummaryAgile Therapeutics is preparing to launch their first FDA approved product, Twirla. If all goes well, Twirla could quickly establish a foothold in a $4.1B addressable . . .
Posted on 12/8/20
Marinus Pharmaceuticals Announces Underwritten Public Offering of Common Stock
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced an underwritten . . .
Posted on 12/8/20
TrekIT Health Rebrands To CareAlign
TrekIt Health, the health IT startup that makes a clinical workflow platform used by physicians, is rebranding to CareAlign
Posted on 12/7/20
This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far
It's not surprising in the least that the stocks of several companies in the race to develop coronavirus vaccines have been sizzling hot so far this . . .
Posted on 12/7/20
Buffett Buys Merck - And You Should, Too
SummaryMerck owns one of the best drugs in the world, Keytruda.The company has a solid growth outlook going forward.An inexpensive valuation and a solid dividend yield . . .
Posted on 12/7/20
Pfizer: Coronavirus Vaccine Playing Out, Still Inexpensive And Offering A High Yield
SummaryPfizer's vaccine for COVID looks promising and should boost revenues substantially.The company is trading at an inexpensive valuation and offers an above-average dividend yield.For those seeking . . .
Posted on 12/7/20
Is Pfizer a Great Dividend Stock?
There's a lot of excitement today surrounding Pfizer (NYSE:PFE) and the COVID-19 vaccine that it's working on with BioNTech. The vaccine is more than 90% effective . . .
Philadelphia
